← Back to Search

MRI

Low Field MRI for Brain Imaging

N/A
Recruiting
Led By Sherwin Chan, MD PhD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 years
Awards & highlights

Study Summary

This trial will see if an MRI with lower magnetic strength can accurately diagnose health issues.

Who is the study for?
This trial is for outpatients aged from birth to 22 years at CMH Adele Hall Radiology. It's not suitable for those who need sedation altered for the study or have non-MRI safe implants that can't be removed.Check my eligibility
What is being tested?
The trial is testing a new early stage MRI system called Hyperfine MRI, which uses low magnetic field strength to perform brain imaging assessments on patients.See study design
What are the potential side effects?
Since this trial involves an imaging technique and not a drug, there are no chemical side effects. However, discomfort or issues related to lying still during the scan may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive Therapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: HyperfineExperimental Treatment1 Intervention
For patients that have standard of care head imaging, we will do a secondary analysis to compare their standard of care MRI, CT and/or US exams with Hyperfine MRI exams.

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
245 Previous Clinical Trials
935,299 Total Patients Enrolled
Sherwin Chan, MD PhDPrincipal InvestigatorChildren's Mercy

Media Library

Hyperfine MRI (MRI) Clinical Trial Eligibility Overview. Trial Name: NCT05582785 — N/A
Brain Imaging Research Study Groups: Hyperfine
Brain Imaging Clinical Trial 2023: Hyperfine MRI Highlights & Side Effects. Trial Name: NCT05582785 — N/A
Hyperfine MRI (MRI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05582785 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for participants in this trial?

"According to the information listed on clinicaltrials.gov, this medical trial began recruiting participants in September of 2022 and has been updated as recently as November 8th, 2022."

Answered by AI

What is the current participation rate of this experiment?

"Affirmative. Per the information on clinicaltrials.gov, this research endeavour is actively seeking volunteers to take part in it. This trial was first posted on September 1st 2022 and last updated November 8th 2022; its scope involves enrolling 500 individuals from a single site."

Answered by AI

Are there any specific demographic requirements for participants in this experiment?

"This trial is looking to recruit 500 individuals with conditions that necessitate brain magnetic resonance imaging, head computerized tomography, or head ultrasound. Additionally all candidates must be between 0 and 22 years of age in order to qualify for the study."

Answered by AI

Are senior citizens of eighty-five years or more eligible to participate in this trial?

"This clinical trial requires participants to be between 0 and 22 years of age, in accordance with the predefined inclusion criteria."

Answered by AI

Who else is applying?

What site did they apply to?
Children's Mercy Kansas City
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Low Field Magnetic Resonance Imaging Assessment With Outpatients
Sherwin Chan MD PhD 2022. "Low Field Magnetic Resonance Imaging Assessment With Outpatients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05582785.
~314 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top